118 related articles for article (PubMed ID: 9645916)
1. Mathematical model for the blood coagulation prothrombin time test.
Khanin MA; Rakov DV; Kogan AE
Thromb Res; 1998 Mar; 89(5):227-32. PubMed ID: 9645916
[TBL] [Abstract][Full Text] [Related]
2. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
Angelos MG; Hamilton GC
Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249
[TBL] [Abstract][Full Text] [Related]
3. Relation of simple clotting tests to clotting factor levels in liver disease.
Ruiz F; Grainger SL; Hall RJ; Ingram GI; Pollard V; Swan AV
Clin Lab Haematol; 1982; 4(3):247-56. PubMed ID: 7172607
[TBL] [Abstract][Full Text] [Related]
4. Coagulation factor analysis in patients on long-term anticoagulation.
Perkins HA; Biben RL
Calif Med; 1970 Mar; 112(3):1-7. PubMed ID: 5451608
[TBL] [Abstract][Full Text] [Related]
5. Normal values of coagulation in canine blood.
Zondag AC; Kolb AM; Bax NM
Haemostasis; 1985; 15(5):318-23. PubMed ID: 4076838
[TBL] [Abstract][Full Text] [Related]
6. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.
Burns ER; Goldberg SN; Wenz B
Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955
[TBL] [Abstract][Full Text] [Related]
7. Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.
Park KJ; Kwon EH; Ma Y; Park IA; Kim SW; Kim SH; Kim HJ
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):35-8. PubMed ID: 22027757
[TBL] [Abstract][Full Text] [Related]
8. The kaolin partial thromboplastin time as a screening test for coagulation disorders.
Lurie A; Smith S
S Afr Med J; 1968 May; 42(18):438-44. PubMed ID: 5655371
[No Abstract] [Full Text] [Related]
9. Clinical implications of clotting screens.
Thorell SE; Nash MJ; Thachil J
Int J Lab Hematol; 2015 Feb; 37(1):8-13. PubMed ID: 24636194
[TBL] [Abstract][Full Text] [Related]
10. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
Reed RL; Bracey AW; Hudson JD; Miller TA; Fischer RP
Circ Shock; 1990 Oct; 32(2):141-52. PubMed ID: 2253317
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the activated partial thromboplastin time test using mathematical modeling.
Kogan AE; Kardakov DV; Khanin MA
Thromb Res; 2001 Feb; 101(4):299-310. PubMed ID: 11248291
[TBL] [Abstract][Full Text] [Related]
12. [Laboratory methods for the estimation of plasma clotting factors. Phase 2].
Kagami M
Rinsho Byori; 1969; 16():Suppl 16:85-92. PubMed ID: 5391589
[No Abstract] [Full Text] [Related]
13. Detection and quantitative evaluation of lupus circulating anticoagulant activity.
Rosner E; Pauzner R; Lusky A; Modan M; Many A
Thromb Haemost; 1987 Apr; 57(2):144-7. PubMed ID: 3110995
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of "Statsep," a semiautomated device to prepare plasma samples for coagulation analysis.
Hoppensteadt D; Walenga JM; Fareed J; Phelan K
Semin Thromb Hemost; 1983 Oct; 9(4):334-40. PubMed ID: 6658464
[No Abstract] [Full Text] [Related]
15. Mathematical modeling of blood coagulation cascade: kinetics of intrinsic and extrinsic pathways in normal and deficient conditions.
Zhu D
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):637-46. PubMed ID: 17890951
[TBL] [Abstract][Full Text] [Related]
16. [Saliva and blood coagulation].
Rioboo Garcia R
Arch Inst Farmacol Exp (Madr); 1970; 22(1-2):21-39. PubMed ID: 5538289
[No Abstract] [Full Text] [Related]
17. In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies.
Toulon P; Eloit Y; Smahi M; Sigaud C; Jambou D; Fischer F; Appert-Flory A
Int J Lab Hematol; 2016 Aug; 38(4):389-96. PubMed ID: 27185477
[TBL] [Abstract][Full Text] [Related]
18. NORMAL VALUES OF CERTAIN FACTORS IN THE BLOOD CLOTTING MECHANISM IN PREGNANCY.
TALBERT LM; LANGDELL RD
Am J Obstet Gynecol; 1964 Sep; 90():44-50. PubMed ID: 14208421
[No Abstract] [Full Text] [Related]
19. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
[TBL] [Abstract][Full Text] [Related]
20. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times.
Kershaw G; Orellana D
Semin Thromb Hemost; 2013 Apr; 39(3):283-90. PubMed ID: 23457048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
